These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Intestinal passage of insulin and proteolytic enzymes]. Nakano A, Sato N, Ohara A, Muramatsu N. Horumon To Rinsho; 1967 May; 15(5):411-7. PubMed ID: 6070988 [No Abstract] [Full Text] [Related]
25. Nonsuppressible insulin-like activity of human serum. Jakob A, Bürgi H, Froesch ER, Labhart A. Ger Med Mon; 1967 Jun; 12(6):286-92. PubMed ID: 4859726 [No Abstract] [Full Text] [Related]
28. Studies of insulin antagonism. I. An artifactual antagonist to insulin and plasma nonsuppressible insulin-like activity occurring in preparation of "albumin". Ensinck JW, Poffenbarger PL, Hogan RA, Williams RH. Diabetes; 1967 May; 16(5):289-301. PubMed ID: 6022555 [No Abstract] [Full Text] [Related]
29. In vitro studies on the degradation and synthesis of serum proteins in placentae. II. Degradation of serum proteins. Komine S. Nihon Juigaku Zasshi; 1964 Apr; 26(2):99-106. PubMed ID: 5896564 [No Abstract] [Full Text] [Related]
31. The kinetics of insulin in man. II. Role of the liver. Ferrannini E, Cobelli C. Diabetes Metab Rev; 1987 Apr; 3(2):365-97. PubMed ID: 3552527 [No Abstract] [Full Text] [Related]
37. Nonsuppressible insulin-like activity of human serum. A potent inhibitor of insulin degradation. Kahn CR, Megyesi K, Roth J. J Clin Invest; 1976 Feb 01; 57(2):526-9. PubMed ID: 1254732 [Abstract] [Full Text] [Related]
38. Nonsuppressible insulin-like activity in human serum. 3. Differentiation of two distinct molecules with nonsuppressible ILA. Jakob A, Hauri C, Froesch ER. J Clin Invest; 1968 Dec 01; 47(12):2678-88. PubMed ID: 5725280 [Abstract] [Full Text] [Related]
39. Insulin and glucagon degradation in livers of sand rats (Psammomys obesus). Ansorge S, Kirschke H, Köhler E, Langner J, Römer I, Wiederanders B. Acta Biol Med Ger; 1977 Dec 01; 36(11-12):1713-21. PubMed ID: 616717 [No Abstract] [Full Text] [Related]